Involvement of transmitters in pituitary adenylate cyclase-activating polypeptide-induced hyperthermia

Regulatory Peptides

Volumn 115, Issue 3, 2003, Pages 187-193

  Pataki, Imre ^a   Adamik, Ágnes ^a   Jászberényi, Miklós ^a   Mácsai, Mónika ^a   Telegdy, Gyula ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Dopamine; Hyperthermia; Neurotransmitters; PACAP; Rat

Indexed keywords

APOMORPHINE; ATROPINE; BICUCULLINE; BROMOCRIPTINE; HALOPERIDOL; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; METHYSERGIDE; NALOXONE; PHENOXYBENZAMINE; POLYPEPTIDE; PROPRANOLOL; RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; DRUG ANTAGONISM; DRUG POTENTIATION; HYPERTHERMIA; MALE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

EID: 0141861935     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00173-3     Document Type: Article

References (36)

1. Arancibia S., Rage F., Astier H., Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology. 64:1996;257-267.
2. Arbogast L.A., Voogt J.L. Pituitary adenylate cyclase-activating polypeptide (PACAP) increases prolactin release and tuberoinfundibular dopaminergic neuronal activity. Brain Res. 655:1994;17-24.
3. Arimura A. Editorial: impaired adaptive thermogenesis in pituitary adenylate cyclase-activating polypeptide-deficient mice. Endocrinology. 143:2002;3715-3716.
4. Billington C.J., Levine A.S. Hypothalamic neuropeptide Y regulation of feeding and energy metabolism. Curr. Opin. Neurobiol. 2:1992;847-851.
5. Chipkin R.E. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats. Pharmacol. Biochem. Behav. 30:1988;683-686.
6. Christophe J. Type I receptors for PACAP (a neuropeptide even more important than VIP?). Biochim. Biophys. Acta. 1154:1993;183-199.
7. D'Agata V., Cavallaro S., Stivala F., Travali S., Canonico P.L. Tissue-specific and developmental expression of pituitary adenylate cyclase-activating polypeptide (PACAP) receptors in rat brain. Eur. J. Neurosci. 8:1996;310-318.
8. Ehymayed H.M., Jansky L. A discrete mode of the antipyretic action of AVP, alpha-MSH and ACTH. Physiol. Res. 41:1992;57-61.
9. Gray S.L., Yamaguchi N., Vencová P., Sherwood N.M. Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology. 143:2002;3946-3954.
10. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R.et al. International union of pharmacology: XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50:1998;265-270.
11. Haughey H.M., Fleckenstein A.E., Metzger R.R., Hanson G.R. The effects of methamphetamine on serotonin transporter activity: role of dopamine and hyperthermia. J. Neurochem. 75:2000;1608-1617.
12. Huang S.K., Pan J.T. Stimulatory effects of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide on tuberoinfundibular dopaminergic neuron activity in estrogen-treated ovariectomized rats and their correlation with prolactin secretion. Neuroendocrinology. 64:1996;208-214.
13. Jarry H., Leonhardt S., Schmidt W.E., Creutzfeldt W., Wuttke W. Contrasting effects of pituitary adenylate cyclase activating polypeptide (PACAP) on in vivo and in vitro prolactin and growth hormone release in male rats. Life Sci. 51:1992;823-830.
14. Kovács A., Telegdy G., Tóth G., Penke B. Neurotransmitter-mediated open-field behavioral action of CGRP. Life Sci. 64:1999;733-740.
15. Köves K., Molnár J., Kántor O., Görcs T.J., Lakatos A., Arimura A. New aspects of the neuroendocrine role of PACAP. Ann. N.Y. Acad. Sci. 805:1996;648-654.
16. Kozicz T., Arimura A. Dopamine- and cyclic AMP-regulated phosphoprotein-immunoreactive neurons activated by acute stress are innervated by fiber terminals immunopositive for pituitary adenylate cyclase-activating polypeptide in the extended amygdala in the rat. Regul. Pept. 109:2002;63-70.
17. Masuo Y., Noguchi J., Morita S., Matsumoto Y. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res. 700:1995;219-226.
18. Masuo Y., Ohtaki T., Masuda Y., Nagai Y., Suno M., Tsuda M.et al. Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain. Neurosci. Lett. 126:1991;103-106.
19. Masuo Y., Suzuki N., Matsumoto H., Tokito F., Matsumoto Y., Tsuda M.et al. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res. 602:1993;57-63.
20. Maurelli M., Marchioni E., Tartara A. EEG and autonomic effects of centrally administered galanin in the rabbit. Boll. Soc. Ital. Biol. Sper. 69:1993;485-491.
21. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M.et al. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commun. 170:1990;643-648.
22. Miyata A., Arimura A., Dahl R.R., Minamino N., Uehara A., Jiang L.et al. Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164:1989;567-574.
23. Moore M.R., Black P.M. Neuropeptides. Neurosurg. Rev. 14:1991;97-110.
24. Nagashima M., Yamada K., Kimura H., Matsumoto S., Furukawa T. Hyperthermia induced by the dopamine D1 receptor agonist SK and F38393 in combination with the dopamine D2 receptor agonist talipexole in the rat. Pharmacol. Biochem. Behav. 43:1992;993-997.
25. Pataki I., Adamik Á., Glover V., Tóth G., Telegdy G. The effects of isatin (indole-2, 3-dione) on pituitary adenylate cyclase-activating polypeptide-induced hyperthermia in rats. BMC Neurosci. 3:2002;2-5.
26. Pataki I., Adamik Á., Mácsai M., Jászberényi M., Telegdy G. Pituitary adenylate cyclase-activating polypeptide induces hyperthermia in the rat. Neuropharmacology. 39:2000;1303-1308.
27. + channels. Eur. J. Pharmacol. 255:1994;25-32.
28. Pellegrino L.J., Pellegrino A.S., Cushman A.J. Stereotaxic atlas of the rat brain. 1979;8-57 Plenum, New York.
29. Sherwood N.M., Krueckl S.L., McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 21:2000;619-670.
30. Székely M. The vagus nerve in thermoregulation and energy metabolism. Auton. Neurosci. 85:2000;26-38.
31. Telegdy G. Neuropeptides and brain function. van Wimersma Greidanus T.B. Front. Horm. Res. 15:1984;1-332.
32. Telegdy G., Adamik A. The action of orexin A on passive avoidance learning. Involvement of transmitters. Regul. Pept. 104:2002;105-110.
33. Telegdy G., Kokavszky K. The action of pituitary adenylate cyclase activating polypeptide (PACAP) on passive avoidance learning. The role of transmitters. Brain Res. 874:2000;194-199.
34. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52:2000;269-324.
35. Yamauchi K., Murakami Y., Koshimura K., Nishiki M., Tanaka J., Kato Y. Involvement of pituitary adenylate cyclase-activating polypeptide in growth hormone secretion induced by serotoninergic mechanisms in the rat. Endocrinology. 137:1996;1693-1697.
36. Zarrindast M.R., Tabatabai S.A. Involvement of dopamine receptor subtypes in mouse thermoregulation. Psychopharmacology. 107:1992;341-346.